vs
DULUTH HOLDINGS INC.（DLTH）与Orthofix Medical Inc.（OFIX）财务数据对比。点击上方公司名可切换其他公司
Orthofix Medical Inc.的季度营收约是DULUTH HOLDINGS INC.的1.9倍（$219.9M vs $114.9M），Orthofix Medical Inc.净利率更高（-1.0% vs -8.8%，领先7.8%），Orthofix Medical Inc.同比增速更快（2.0% vs -9.6%），Orthofix Medical Inc.自由现金流更多（$16.8M vs $-8.9M），过去两年Orthofix Medical Inc.的营收复合增速更高（8.0% vs -31.6%）
德卢思控股是一家美国工装及配饰企业，主打通过旗下德卢思贸易品牌开展产品销售业务，面向市场推出各类实用工装及相关配饰产品，是美国本土颇具特色的服饰零售企业。
Orthofix医疗是全球知名骨科医疗器械企业，专注于研发、生产及销售脊柱植入物、骨科创伤产品、骨生长刺激治疗设备及再生医疗产品，服务全球多地的骨科医师与医疗机构，致力于提升肌肉骨骼疾病患者的诊疗效果。
DLTH vs OFIX — 直观对比
营收规模更大
OFIX
是对方的1.9倍
$114.9M
营收增速更快
OFIX
高出11.6%
-9.6%
净利率更高
OFIX
高出7.8%
-8.8%
自由现金流更多
OFIX
多$25.8M
$-8.9M
两年增速更快
OFIX
近两年复合增速
-31.6%
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $114.9M | $219.9M |
| 净利润 | $-10.1M | $-2.2M |
| 毛利率 | 53.8% | 71.1% |
| 营业利润率 | -7.7% | 0.2% |
| 净利率 | -8.8% | -1.0% |
| 营收同比 | -9.6% | 2.0% |
| 净利润同比 | 64.6% | 92.4% |
| 每股收益（稀释后） | $-0.29 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DLTHOFIX
| Q4 25 | $114.9M | $219.9M | ||
| Q3 25 | $131.7M | $205.6M | ||
| Q2 25 | $102.7M | $203.1M | ||
| Q1 25 | $241.3M | $193.6M | ||
| Q4 24 | $127.1M | $215.7M | ||
| Q3 24 | $141.6M | $196.6M | ||
| Q2 24 | $116.7M | $198.6M | ||
| Q1 24 | $245.6M | $188.6M |
净利润DLTHOFIX
| Q4 25 | $-10.1M | $-2.2M | ||
| Q3 25 | $1.3M | $-22.8M | ||
| Q2 25 | $-15.3M | $-14.1M | ||
| Q1 25 | $-5.6M | $-53.1M | ||
| Q4 24 | $-28.2M | $-29.1M | ||
| Q3 24 | $-2.0M | $-27.4M | ||
| Q2 24 | $-7.9M | $-33.4M | ||
| Q1 24 | $6.4M | $-36.0M |
毛利率DLTHOFIX
| Q4 25 | 53.8% | 71.1% | ||
| Q3 25 | 54.7% | 72.2% | ||
| Q2 25 | 52.0% | 68.7% | ||
| Q1 25 | 44.1% | 62.8% | ||
| Q4 24 | 52.3% | 69.0% | ||
| Q3 24 | 52.3% | 68.7% | ||
| Q2 24 | 52.8% | 67.8% | ||
| Q1 24 | 48.2% | 67.5% |
营业利润率DLTHOFIX
| Q4 25 | -7.7% | 0.2% | ||
| Q3 25 | 1.8% | -8.3% | ||
| Q2 25 | -12.0% | -7.9% | ||
| Q1 25 | -1.8% | -25.2% | ||
| Q4 24 | -17.4% | -5.3% | ||
| Q3 24 | -1.1% | -9.6% | ||
| Q2 24 | -7.7% | -12.5% | ||
| Q1 24 | 3.6% | -15.6% |
净利率DLTHOFIX
| Q4 25 | -8.8% | -1.0% | ||
| Q3 25 | 1.0% | -11.1% | ||
| Q2 25 | -14.9% | -6.9% | ||
| Q1 25 | -2.3% | -27.4% | ||
| Q4 24 | -22.2% | -13.5% | ||
| Q3 24 | -1.4% | -13.9% | ||
| Q2 24 | -6.7% | -16.8% | ||
| Q1 24 | 2.6% | -19.1% |
每股收益（稀释后）DLTHOFIX
| Q4 25 | $-0.29 | $-0.05 | ||
| Q3 25 | $0.04 | $-0.57 | ||
| Q2 25 | $-0.45 | $-0.36 | ||
| Q1 25 | $-0.17 | $-1.35 | ||
| Q4 24 | $-0.84 | $-0.76 | ||
| Q3 24 | $-0.06 | $-0.71 | ||
| Q2 24 | $-0.24 | $-0.88 | ||
| Q1 24 | $0.20 | $-0.95 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $8.2M | $82.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $160.6M | $450.0M |
| 总资产 | $468.0M | $850.6M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资DLTHOFIX
| Q4 25 | $8.2M | $82.0M | ||
| Q3 25 | $5.7M | $62.9M | ||
| Q2 25 | $8.6M | $65.6M | ||
| Q1 25 | $3.3M | $58.0M | ||
| Q4 24 | $9.3M | $83.2M | ||
| Q3 24 | $9.8M | $30.1M | ||
| Q2 24 | $6.8M | $26.4M | ||
| Q1 24 | $32.2M | $27.0M |
总债务DLTHOFIX
| Q4 25 | — | — | ||
| Q3 25 | — | $157.2M | ||
| Q2 25 | — | $157.0M | ||
| Q1 25 | — | $156.9M | ||
| Q4 24 | — | $157.0M | ||
| Q3 24 | — | $118.5M | ||
| Q2 24 | — | $118.0M | ||
| Q1 24 | — | $118.2M |
股东权益DLTHOFIX
| Q4 25 | $160.6M | $450.0M | ||
| Q3 25 | $170.0M | $442.5M | ||
| Q2 25 | $167.9M | $458.3M | ||
| Q1 25 | $182.7M | $458.3M | ||
| Q4 24 | $188.1M | $503.1M | ||
| Q3 24 | $215.7M | $525.9M | ||
| Q2 24 | $218.4M | $546.0M | ||
| Q1 24 | $222.8M | $570.3M |
总资产DLTHOFIX
| Q4 25 | $468.0M | $850.6M | ||
| Q3 25 | $433.8M | $832.6M | ||
| Q2 25 | $463.7M | $837.2M | ||
| Q1 25 | $452.4M | $823.1M | ||
| Q4 24 | $533.1M | $893.3M | ||
| Q3 24 | $488.6M | $867.9M | ||
| Q2 24 | $471.4M | $882.0M | ||
| Q1 24 | $491.2M | $906.0M |
负债/权益比DLTHOFIX
| Q4 25 | — | — | ||
| Q3 25 | — | 0.36× | ||
| Q2 25 | — | 0.34× | ||
| Q1 25 | — | 0.34× | ||
| Q4 24 | — | 0.31× | ||
| Q3 24 | — | 0.23× | ||
| Q2 24 | — | 0.22× | ||
| Q1 24 | — | 0.21× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-6.7M | $27.7M |
| 自由现金流经营现金流 - 资本支出 | $-8.9M | $16.8M |
| 自由现金流率自由现金流/营收 | -7.8% | 7.6% |
| 资本支出强度资本支出/营收 | 2.0% | 4.9% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $1.7M | $-1.3M |
8季度趋势，按日历期对齐
经营现金流DLTHOFIX
| Q4 25 | $-6.7M | $27.7M | ||
| Q3 25 | $32.0M | $12.4M | ||
| Q2 25 | $-56.5M | $11.6M | ||
| Q1 25 | $41.2M | $-18.4M | ||
| Q4 24 | $-41.1M | $23.7M | ||
| Q3 24 | $16.6M | $11.7M | ||
| Q2 24 | $-33.7M | $9.0M | ||
| Q1 24 | $69.7M | $-18.6M |
自由现金流DLTHOFIX
| Q4 25 | $-8.9M | $16.8M | ||
| Q3 25 | $29.8M | $2.5M | ||
| Q2 25 | $-57.8M | $4.5M | ||
| Q1 25 | $38.7M | $-25.1M | ||
| Q4 24 | $-43.7M | $15.2M | ||
| Q3 24 | $15.0M | $6.3M | ||
| Q2 24 | $-35.2M | $-360.0K | ||
| Q1 24 | $60.6M | $-29.1M |
自由现金流率DLTHOFIX
| Q4 25 | -7.8% | 7.6% | ||
| Q3 25 | 22.6% | 1.2% | ||
| Q2 25 | -56.3% | 2.2% | ||
| Q1 25 | 16.0% | -13.0% | ||
| Q4 24 | -34.4% | 7.0% | ||
| Q3 24 | 10.6% | 3.2% | ||
| Q2 24 | -30.2% | -0.2% | ||
| Q1 24 | 24.7% | -15.4% |
资本支出强度DLTHOFIX
| Q4 25 | 2.0% | 4.9% | ||
| Q3 25 | 1.7% | 4.8% | ||
| Q2 25 | 1.3% | 3.5% | ||
| Q1 25 | 1.0% | 3.5% | ||
| Q4 24 | 2.1% | 4.0% | ||
| Q3 24 | 1.2% | 2.7% | ||
| Q2 24 | 1.3% | 4.7% | ||
| Q1 24 | 3.7% | 5.6% |
现金转化率DLTHOFIX
| Q4 25 | — | — | ||
| Q3 25 | 25.40× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 10.86× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DLTH
| Sales Channel Directly To Consumer | $67.4M | 59% |
| Sales Channel Through Intermediary | $47.4M | 41% |
OFIX
| Spinal Implants Biologics And Enabling Technologies | $113.6M | 52% |
| Bone Growth Therapies | $68.3M | 31% |
| Other | $22.7M | 10% |
| IT | $5.9M | 3% |
| GB | $3.5M | 2% |
| FR | $3.5M | 2% |
| DE | $2.3M | 1% |
